Acinetobacter species are becoming a major cause of nosocomial infections, including hospital-acquired and ventilator-associated pneumonia. Acinetobacter species have become increasingly resistant to antibiotics over the past several years and currently present a significant challenge in treating these infections. Physicians now rely on older agents, such as polymyxins (colistin), for treatment. This paper reviews the epidemiology, treatment, and prevention of this emerging pathogen.
|Original language||English (US)|
|Journal||MedGenMed Medscape General Medicine|
|Publication status||Published - Jul 16 2007|
ASJC Scopus subject areas